Proteomic Analyses of Pancreatic Cyst Fluids

From the Divisions of *Basic Science, daggerMedical Science, and double daggerPopulation Science, Fox Chase Cancer Center, Philadelphia, PA.
Pancreas (Impact Factor: 2.96). 02/2009; 38(2):e33-42. DOI: 10.1097/MPA.0b013e318193a08f
Source: PubMed


There are currently no diagnostic indicators that are consistently reliable, obtainable, and conclusive for diagnosing and risk-stratifying pancreatic cysts. Proteomic analyses were performed to explore pancreatic cyst fluids to yield effective diagnostic biomarkers.
We have prospectively recruited 20 research participants and prepared their pancreatic cyst fluids specifically for proteomic analyses. Proteomic approaches applied were as follows: (1) matrix-assisted laser-desorption-ionization time-of-flight mass spectrometry peptidomics with LC/MS/MS (HPLC-tandem mass spectrometry) protein identification; (2) 2-dimensional gel electrophoresis; (3) GeLC/MS/MS (tryptic digestion of proteins fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and identified by LC/MS/MS).
Sequencing of more than 350 free peptides showed that exopeptidase activities rendered peptidomics of cyst fluids unreliable; protein nicking by proteases in the cyst fluids produced hundreds of protein spots from the major proteins, making 2-dimensional gel proteomics unmanageable; GeLC/MS/MS revealed a panel of potential biomarker proteins that correlated with carcinoembryonic antigen (CEA).
Two homologs of amylase, solubilized molecules of 4 mucins, 4 solubilized CEA-related cell adhesion molecules (CEACAMs), and 4 S100 homologs may be candidate biomarkers to facilitate future pancreatic cyst diagnosis and risk-stratification. This approach required less than 40 microL of cyst fluid per sample, offering the possibility to analyze cysts smaller than 1 cm in diameter.

Download full-text


Available from: David S Weinberg
  • Source
    • "Existing tumor markers have only limited value, and more sensitive biomarkers need to be identified. New techniques including proteomics and molecular analysis may be helpful for the differential diagnosis of pancreatic cysts [59]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although little is known on the true prevalence of pancreatic cysts, physicians are currently more frequently confronted with pancreatic cysts because of the increasing use of sophisticated cross-sectional abdominal imaging. Cystic lesions of the pancreas comprise of a heterogeneous group of diagnostic entities, some of which are benign such as inflammatory pseudocysts or serous cystadenomas and do not require resection when asymptomatic. Others like mucinous cysts or intraductal papillary mucinous neoplasms (IPMN) have a malignant potential and in these cases surgical resection is often indicated. For this reason an adequate distinction between the various cysts is crucial to optimize management strategy. Different diagnostic methods that could be of value in the differentiation include radiologic imaging techniques such as CT, MR, and endosonography. In addition, fluid aspiration for cytopathology, tumormarkers or molecular analysis is widely used. Different guidelines are available but so far no optimal diagnostic algorithm exists. We summarize the epidemiology, classification, clinical presentation, diagnostics, management, and future perspectives.
    Full-text · Article · Jan 2012 · Gastroenterology Research and Practice
  • Source
    • "Fluid was analyzed using MALDI-TOF mass spectrometry with LC/MS/MS protein identification, 2D gel electrophoresis, or GeLC/MS/MS (tryptic digestion of proteins fractionated by SDS-PAGE and identified by LC/MS/MS). The first two techniques proved to be unsatisfactory, presumably from endogenous peptidases which splintered native proteins in numerous locations [81]. Mass spectrometry yielded homologs within three families of proteins associated with pancreatic cancer, including mucins, CEACAMs, and S100s. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Proteomics is a powerful method used to identify, characterize, and quantify proteins within biologic samples. Pancreatic cystic neoplasms are a common clinical entity and represent a diagnostic and management challenge due to difficulties in accurately diagnosing cystic lesions with malignant potential and assessing the risk of malignant degeneration. Currently, cytology and other biomarkers in cyst fluid have had limited success in accurately distinguishing both the type of cystic neoplasm and the presence of malignancy. Emerging data suggests that the use of protein-based biomarkers may have greater utility in helping clinicians correctly diagnose the type of cyst and to identify which cystic neoplasms are malignant. Several candidate proteins have been identified within pancreatic cystic neoplasms as potential biomarkers. Future studies will be needed to validate these findings and move these biomarkers into the clinical setting.
    Full-text · Article · Oct 2011
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The function of the exocrine pancreas is the production and secretion of digestive enzymes. Major pathologies of the exocrine pancreas are pancreatitis, a sterile inflammation, and pancreatic adenocarcinoma, a highly lethal tumor. Both diseases involve cells of the immune system and calcium binding proteins of the S100 family. Here, we review the known function of these proteins in pancreatitis and pancreas cancer. Few S100 proteins were detected during pancreatitis and only for the S100A8/A9 complex data are available that eluci-date a presumable function. In a rodent model of caerulein-induced acute pancreatitis, pancreatic S100A8/A9 expression was exclusively detected in infiltrating leukocytes. S100A9 knockout animals developed less pancreatic tissue damage, no significant edema formation, and the intrapancreatic infiltration of leukocytes was inhibited. Purified S100A8/A9 dissoci-ated calcium-dependent cell-cell contacts between pancreatic acinar cells in vitro and in vivo. These results indicate that the dissociation of epithelial cell-cell contacts mediated by secreted S100A8/A9 is crucial for the infiltration of leukocytes into the pancreas. Several studies revealed an expression of S100 proteins in pancreatic cancers. Especially S100A8/A9 proteins were found in myeloid cells within tumor-associated stroma. Whether these proteins contribute to a recruitment of specific immune cells to tumors or to other steps of pancreatic tumor progression is not clear. None of the S100 proteins has been clearly confirmed as a pancrea tumor marker. Taken together, S100A8/A9 proteins are essential for the inflammation induced infiltration of leukocytes in murine pan-creatic tissue a mechanism which may also support tumor progression and metastasis.
    Full-text · Article · Jan 2010 · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Cu rrent Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents)
Show more